06 Feb2019

Omron Healthcare and physIQ Partner to Transform Cardiovascular Patient Care

Written by 2020HCP.com. Posted in News

  • Omron HeartGuide™, the first wearable blood pressure device, will integrate with physIQ’s pinpointIQ® analytics platform to indicate a potential health risk
  • This combined solution is being deployed to help manage recently-discharged, at-risk patients
  • The goal is to provide clinicians with physiological insight to proactively address potential clinical deterioration
CHICAGO, February 6, 2019 – Omron Healthcare, Inc. and physIQ Inc. today announced a collaboration to integrate Omron’s innovative FDA-cleared device, HeartGuide™, the first wearable blood pressure monitor into the pinpointIQ® platform to monitor at-risk patients in an outpatient setting. The strategic collaboration aims to generate actionable clinical information for at-risk patients in an outpatient environment by leveraging the complementary technologies of each company. Omron is the global leader in personal heart health and wellness technology and physIQ is a pioneer in FDA-cleared Artificial Intelligence physiology analytics.
09 Jan2019

ENCOMPASS ANNOUNCES PARTNERSHIP WITH ZIXI

Written by 2020HCP.com. Posted in News

Encompass Digital Media, a global technology services company delivering end-to-end video playout and distribution solutions to broadcast and digital media companies, announces its partnership with Zixi, the industry leader for enabling dependable, live broadcast-quality video over the internet. Zixi’s proven, best-of-breed solutions coupled with Encompass’ broadcast expertise gives its clients additional economical methods to acquire and deliver content.   READ MORE
03 Jan2019

SQZ Biotech Strengthens Leadership Team with Appointment of Chief Medical Officer

Written by 2020HCP.com. Posted in News

Industry veteran, Oliver Rosen, MD, to join executive team as SQZ prepares to enter the clinic WATERTOWN, Mass., Jan. 3, 2019 –- SQZ Biotechnologies (SQZ), a cell therapy company developing novel treatments for multiple therapeutic areas, today announced the appointment of Oliver Rosen, MD, as Chief Medical Officer. Dr. Rosen will oversee the clinical development of SQZ’s cell therapy pipeline and joins the company as it prepares to enter the clinic with a lead oncology candidate.

Latest News